| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calmodulin binding | 4.51e-03 | 230 | 9 | 2 | GO:0005516 | |
| GeneOntologyBiologicalProcess | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening | 1.54e-05 | 14 | 9 | 2 | GO:0060213 | |
| GeneOntologyBiologicalProcess | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 2.02e-05 | 16 | 9 | 2 | GO:1900153 | |
| GeneOntologyBiologicalProcess | regulation of nuclear-transcribed mRNA poly(A) tail shortening | 2.02e-05 | 16 | 9 | 2 | GO:0060211 | |
| GeneOntologyBiologicalProcess | nuclear-transcribed mRNA catabolic process | 2.09e-05 | 132 | 9 | 3 | GO:0000956 | |
| GeneOntologyBiologicalProcess | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 5.91e-05 | 27 | 9 | 2 | GO:1900151 | |
| GeneOntologyBiologicalProcess | mRNA destabilization | 7.89e-05 | 206 | 9 | 3 | GO:0061157 | |
| GeneOntologyBiologicalProcess | RNA destabilization | 8.47e-05 | 211 | 9 | 3 | GO:0050779 | |
| GeneOntologyBiologicalProcess | positive regulation of mRNA catabolic process | 8.47e-05 | 211 | 9 | 3 | GO:0061014 | |
| GeneOntologyBiologicalProcess | nuclear-transcribed mRNA poly(A) tail shortening | 8.87e-05 | 33 | 9 | 2 | GO:0000289 | |
| GeneOntologyBiologicalProcess | positive regulation of mRNA metabolic process | 1.55e-04 | 259 | 9 | 3 | GO:1903313 | |
| GeneOntologyBiologicalProcess | regulation of mRNA stability | 2.21e-04 | 292 | 9 | 3 | GO:0043488 | |
| GeneOntologyBiologicalProcess | regulation of RNA stability | 2.59e-04 | 308 | 9 | 3 | GO:0043487 | |
| GeneOntologyBiologicalProcess | regulation of mRNA catabolic process | 2.62e-04 | 309 | 9 | 3 | GO:0061013 | |
| GeneOntologyBiologicalProcess | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 3.47e-04 | 65 | 9 | 2 | GO:0000288 | |
| GeneOntologyBiologicalProcess | sister chromatid cohesion | 3.69e-04 | 67 | 9 | 2 | GO:0007062 | |
| GeneOntologyBiologicalProcess | mRNA catabolic process | 4.54e-04 | 373 | 9 | 3 | GO:0006402 | |
| GeneOntologyBiologicalProcess | RNA catabolic process | 6.98e-04 | 432 | 9 | 3 | GO:0006401 | |
| GeneOntologyBiologicalProcess | regulation of mRNA metabolic process | 7.51e-04 | 443 | 9 | 3 | GO:1903311 | |
| GeneOntologyBiologicalProcess | nucleic acid catabolic process | 8.59e-04 | 464 | 9 | 3 | GO:0141188 | |
| GeneOntologyBiologicalProcess | miRNA-mediated gene silencing by inhibition of translation | 9.20e-04 | 106 | 9 | 2 | GO:0035278 | |
| GeneOntologyBiologicalProcess | nucleobase-containing compound catabolic process | 2.76e-03 | 696 | 9 | 3 | GO:0034655 | |
| GeneOntologyBiologicalProcess | positive regulation of catabolic process | 2.82e-03 | 701 | 9 | 3 | GO:0009896 | |
| GeneOntologyBiologicalProcess | regulatory ncRNA-mediated gene silencing | 2.99e-03 | 716 | 9 | 3 | GO:0031047 | |
| GeneOntologyBiologicalProcess | female gamete generation | 3.98e-03 | 223 | 9 | 2 | GO:0007292 | |
| GeneOntologyBiologicalProcess | negative regulation of translation | 4.23e-03 | 230 | 9 | 2 | GO:0017148 | |
| GeneOntologyBiologicalProcess | positive regulation of synaptic transmission | 4.34e-03 | 233 | 9 | 2 | GO:0050806 | |
| GeneOntologyCellularComponent | mitotic cohesin complex | 3.46e-06 | 7 | 9 | 2 | GO:0030892 | |
| GeneOntologyCellularComponent | cohesin complex | 9.04e-06 | 11 | 9 | 2 | GO:0008278 | |
| GeneOntologyCellularComponent | presynaptic membrane | 1.82e-04 | 277 | 9 | 3 | GO:0042734 | |
| GeneOntologyCellularComponent | hippocampal mossy fiber to CA3 synapse | 3.59e-04 | 67 | 9 | 2 | GO:0098686 | |
| GeneOntologyCellularComponent | P-body | 8.30e-04 | 102 | 9 | 2 | GO:0000932 | |
| GeneOntologyCellularComponent | excitatory synapse | 9.13e-04 | 107 | 9 | 2 | GO:0060076 | |
| GeneOntologyCellularComponent | synaptic membrane | 1.60e-03 | 583 | 9 | 3 | GO:0097060 | |
| GeneOntologyCellularComponent | glutamatergic synapse | 4.19e-03 | 817 | 9 | 3 | GO:0098978 | |
| GeneOntologyCellularComponent | presynapse | 5.26e-03 | 886 | 9 | 3 | GO:0098793 | |
| GeneOntologyCellularComponent | axon | 5.34e-03 | 891 | 9 | 3 | GO:0030424 | |
| GeneOntologyCellularComponent | cytoplasmic ribonucleoprotein granule | 5.60e-03 | 269 | 9 | 2 | GO:0036464 | |
| GeneOntologyCellularComponent | chromosome, centromeric region | 5.88e-03 | 276 | 9 | 2 | GO:0000775 | |
| GeneOntologyCellularComponent | ribonucleoprotein granule | 6.35e-03 | 287 | 9 | 2 | GO:0035770 | |
| GeneOntologyCellularComponent | chromosomal region | 1.33e-02 | 421 | 9 | 2 | GO:0098687 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | 2.00e-02 | 523 | 9 | 2 | GO:0098984 | |
| Domain | Ago_hook | 6.19e-07 | 3 | 9 | 2 | PF10427 | |
| Domain | TNRC6_PABC-bd | 6.19e-07 | 3 | 9 | 2 | IPR032226 | |
| Domain | Argonaute_hook_dom | 6.19e-07 | 3 | 9 | 2 | IPR019486 | |
| Domain | TNRC6-PABC_bdg | 6.19e-07 | 3 | 9 | 2 | PF16608 | |
| Domain | UBA-like | 4.10e-04 | 64 | 9 | 2 | IPR009060 | |
| Domain | RRM | 5.13e-03 | 230 | 9 | 2 | PS50102 | |
| Domain | - | 5.76e-03 | 244 | 9 | 2 | 3.30.70.330 | |
| Domain | Nucleotide-bd_a/b_plait | 6.42e-03 | 258 | 9 | 2 | IPR012677 | |
| Pathway | REACTOME_POST_TRANSCRIPTIONAL_SILENCING_BY_SMALL_RNAS | 7.60e-06 | 7 | 9 | 2 | M46421 | |
| Pathway | REACTOME_REGULATION_OF_PTEN_MRNA_TRANSLATION | 1.30e-05 | 9 | 9 | 2 | M27810 | |
| Pathway | REACTOME_REGULATION_OF_NPAS4_MRNA_TRANSLATION | 1.30e-05 | 9 | 9 | 2 | M46436 | |
| Pathway | REACTOME_REGULATION_OF_CDH11_MRNA_TRANSLATION_BY_MICRORNAS | 1.63e-05 | 10 | 9 | 2 | M48013 | |
| Pathway | REACTOME_REGULATION_OF_NPAS4_GENE_EXPRESSION | 2.82e-05 | 13 | 9 | 2 | M46434 | |
| Pathway | REACTOME_REGULATION_OF_RUNX1_EXPRESSION_AND_ACTIVITY | 4.90e-05 | 17 | 9 | 2 | M27788 | |
| Pathway | REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_APOPTOSIS | 6.16e-05 | 19 | 9 | 2 | M48238 | |
| Pathway | REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION | 9.28e-05 | 149 | 9 | 3 | M27888 | |
| Pathway | REACTOME_TGFBR3_EXPRESSION | 1.36e-04 | 28 | 9 | 2 | M48253 | |
| Pathway | REACTOME_REGULATION_OF_HOMOTYPIC_CELL_CELL_ADHESION | 1.78e-04 | 32 | 9 | 2 | M48012 | |
| Pathway | REACTOME_REGULATION_OF_MECP2_EXPRESSION_AND_ACTIVITY | 1.78e-04 | 32 | 9 | 2 | M27900 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_NPAS4 | 2.01e-04 | 34 | 9 | 2 | M46422 | |
| Pathway | WP_COHESIN_COMPLEX_CORNELIA_DE_LANGE_SYNDROME | 2.01e-04 | 34 | 9 | 2 | M42555 | |
| Pathway | REACTOME_ONCOGENE_INDUCED_SENESCENCE | 2.13e-04 | 35 | 9 | 2 | M27190 | |
| Pathway | REACTOME_NR1H3_NR1H2_REGULATE_GENE_EXPRESSION_LINKED_TO_CHOLESTEROL_TRANSPORT_AND_EFFLUX | 2.39e-04 | 37 | 9 | 2 | M29790 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_VENTX | 2.93e-04 | 41 | 9 | 2 | M29748 | |
| Pathway | REACTOME_ESR_MEDIATED_SIGNALING | 2.94e-04 | 220 | 9 | 3 | M27794 | |
| Pathway | REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING | 3.86e-04 | 47 | 9 | 2 | M29777 | |
| Pathway | REACTOME_SIGNALING_BY_TGFBR3 | 4.20e-04 | 49 | 9 | 2 | M48250 | |
| Pathway | REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS | 5.88e-04 | 58 | 9 | 2 | M11980 | |
| Pathway | REACTOME_CA2_PATHWAY | 6.72e-04 | 62 | 9 | 2 | M27321 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_MECP2 | 6.93e-04 | 63 | 9 | 2 | M27862 | |
| Pathway | REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS | 7.01e-04 | 296 | 9 | 3 | M27869 | |
| Pathway | REACTOME_TP53_REGULATES_METABOLIC_GENES | 1.23e-03 | 84 | 9 | 2 | M27495 | |
| Pathway | REACTOME_CELL_CELL_JUNCTION_ORGANIZATION | 1.41e-03 | 90 | 9 | 2 | M820 | |
| Pathway | REACTOME_MAPK6_MAPK4_SIGNALING | 1.50e-03 | 93 | 9 | 2 | M27572 | |
| Pathway | REACTOME_MITF_M_DEPENDENT_GENE_EXPRESSION | 1.57e-03 | 95 | 9 | 2 | M48268 | |
| Pathway | REACTOME_RUNX1_REGULATES_GENES_INVOLVED_IN_MEGAKARYOCYTE_DIFFERENTIATION_AND_PLATELET_FUNCTION | 1.60e-03 | 96 | 9 | 2 | M27792 | |
| Pathway | REACTOME_CELL_JUNCTION_ORGANIZATION | 2.37e-03 | 117 | 9 | 2 | M19248 | |
| Pathway | REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING | 2.45e-03 | 119 | 9 | 2 | M607 | |
| Pathway | REACTOME_OXIDATIVE_STRESS_INDUCED_SENESCENCE | 2.70e-03 | 125 | 9 | 2 | M27186 | |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | 2.78e-03 | 127 | 9 | 2 | M27181 | |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | 2.87e-03 | 129 | 9 | 2 | MM14894 | |
| Pathway | REACTOME_MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT | 3.23e-03 | 137 | 9 | 2 | M48232 | |
| Pathway | REACTOME_PTEN_REGULATION | 3.32e-03 | 139 | 9 | 2 | M27646 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 3.32e-03 | 139 | 9 | 2 | M715 | |
| Pathway | REACTOME_BETA_CATENIN_INDEPENDENT_WNT_SIGNALING | 3.66e-03 | 146 | 9 | 2 | M27288 | |
| Pathway | REACTOME_CELL_CELL_COMMUNICATION | 4.11e-03 | 155 | 9 | 2 | M522 | |
| Pathway | REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS | 4.43e-03 | 161 | 9 | 2 | M27871 | |
| Pathway | REACTOME_SEPARATION_OF_SISTER_CHROMATIDS | 6.18e-03 | 191 | 9 | 2 | M29614 | |
| Pathway | REACTOME_SEPARATION_OF_SISTER_CHROMATIDS | 6.30e-03 | 193 | 9 | 2 | MM14890 | |
| Pathway | REACTOME_CELLULAR_SENESCENCE | 6.56e-03 | 197 | 9 | 2 | M27188 | |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | 6.88e-03 | 202 | 9 | 2 | MM15362 | |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | 7.02e-03 | 204 | 9 | 2 | M4217 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | 8.79e-03 | 1432 | 9 | 4 | M509 | |
| Pathway | REACTOME_MITOTIC_METAPHASE_AND_ANAPHASE | 9.15e-03 | 234 | 9 | 2 | MM14898 | |
| Pathway | REACTOME_MITOTIC_METAPHASE_AND_ANAPHASE | 9.30e-03 | 236 | 9 | 2 | M27185 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1 | 9.37e-03 | 237 | 9 | 2 | M27786 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 1.01e-02 | 246 | 9 | 2 | M10189 | |
| Pathway | REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS | 1.60e-02 | 313 | 9 | 2 | M27867 | |
| Pathway | REACTOME_MAPK_FAMILY_SIGNALING_CASCADES | 1.73e-02 | 327 | 9 | 2 | M27565 | |
| Pathway | REACTOME_SIGNALING_BY_WNT | 1.76e-02 | 330 | 9 | 2 | M7847 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_TP53 | 2.08e-02 | 360 | 9 | 2 | M27267 | |
| Pubmed | 1.79e-07 | 3 | 9 | 2 | 16880270 | ||
| Pubmed | Impact of scaffolding protein TNRC6 paralogs on gene expression and splicing. | 1.79e-07 | 3 | 9 | 2 | 34108231 | |
| Pubmed | 1.79e-07 | 3 | 9 | 2 | 31670606 | ||
| Pubmed | Two PABPC1-binding sites in GW182 proteins promote miRNA-mediated gene silencing. | 3.57e-07 | 4 | 9 | 2 | 21063388 | |
| Pubmed | Ago-TNRC6 triggers microRNA-mediated decay by promoting two deadenylation steps. | 5.95e-07 | 5 | 9 | 2 | 19838187 | |
| Pubmed | 1.25e-06 | 7 | 9 | 2 | 19383768 | ||
| Pubmed | Functional dissection of the human TNRC6 (GW182-related) family of proteins. | 1.25e-06 | 7 | 9 | 2 | 19470757 | |
| Pubmed | Mammalian miRNA RISC recruits CAF1 and PABP to affect PABP-dependent deadenylation. | 5.41e-06 | 14 | 9 | 2 | 19716330 | |
| Pubmed | GW182 proteins directly recruit cytoplasmic deadenylase complexes to miRNA targets. | 6.24e-06 | 15 | 9 | 2 | 21981923 | |
| Pubmed | 1.37e-05 | 22 | 9 | 2 | 22187428 | ||
| Pubmed | 1.37e-05 | 22 | 9 | 2 | 21690297 | ||
| Pubmed | 1.50e-05 | 23 | 9 | 2 | 28811219 | ||
| Pubmed | USP45 and Spindly are part of the same complex implicated in cell migration. | 2.48e-05 | 235 | 9 | 3 | 30258100 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 6.35e-05 | 954 | 9 | 4 | 36373674 | |
| Pubmed | 8.46e-05 | 54 | 9 | 2 | 26288249 | ||
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | 9.04e-05 | 363 | 9 | 3 | 14691545 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 1.60e-04 | 440 | 9 | 3 | 34244565 | |
| Pubmed | 1.86e-04 | 80 | 9 | 2 | 35803934 | ||
| Interaction | IQCC interactions | 1.61e-05 | 14 | 9 | 2 | int:IQCC | |
| Interaction | KIF23 interactions | 3.68e-05 | 1031 | 9 | 5 | int:KIF23 | |
| Interaction | KIZ interactions | 6.19e-05 | 27 | 9 | 2 | int:KIZ | |
| Interaction | SEC23B interactions | 1.05e-04 | 222 | 9 | 3 | int:SEC23B | |
| Interaction | SEC24A interactions | 1.08e-04 | 224 | 9 | 3 | int:SEC24A | |
| Interaction | SEC24B interactions | 1.33e-04 | 240 | 9 | 3 | int:SEC24B | |
| Interaction | CNOT6 interactions | 2.70e-04 | 56 | 9 | 2 | int:CNOT6 | |
| Interaction | SPDL1 interactions | 2.96e-04 | 315 | 9 | 3 | int:SPDL1 | |
| Interaction | PAN3 interactions | 3.63e-04 | 65 | 9 | 2 | int:PAN3 | |
| Interaction | FAM184A interactions | 4.46e-04 | 72 | 9 | 2 | int:FAM184A | |
| Interaction | CNOT8 interactions | 4.71e-04 | 74 | 9 | 2 | int:CNOT8 | |
| Interaction | GPBP1 interactions | 4.84e-04 | 75 | 9 | 2 | int:GPBP1 | |
| Interaction | DCAF4 interactions | 5.06e-04 | 378 | 9 | 3 | int:DCAF4 | |
| Interaction | CTIF interactions | 5.10e-04 | 77 | 9 | 2 | int:CTIF | |
| Interaction | MKRN2 interactions | 5.33e-04 | 385 | 9 | 3 | int:MKRN2 | |
| Interaction | TBKBP1 interactions | 5.50e-04 | 80 | 9 | 2 | int:TBKBP1 | |
| Interaction | NR3C1 interactions | 5.62e-04 | 974 | 9 | 4 | int:NR3C1 | |
| Interaction | HECTD1 interactions | 5.84e-04 | 984 | 9 | 4 | int:HECTD1 | |
| Interaction | SMC5 interactions | 6.21e-04 | 1000 | 9 | 4 | int:SMC5 | |
| Interaction | GPBP1L1 interactions | 6.35e-04 | 86 | 9 | 2 | int:GPBP1L1 | |
| Interaction | SPATA2 interactions | 6.50e-04 | 87 | 9 | 2 | int:SPATA2 | |
| Interaction | DGUOK interactions | 7.11e-04 | 91 | 9 | 2 | int:DGUOK | |
| Interaction | CNOT6L interactions | 7.43e-04 | 93 | 9 | 2 | int:CNOT6L | |
| Interaction | MPHOSPH9 interactions | 7.75e-04 | 95 | 9 | 2 | int:MPHOSPH9 | |
| Interaction | CAPRIN1 interactions | 8.46e-04 | 451 | 9 | 3 | int:CAPRIN1 | |
| Interaction | ETV6 interactions | 9.45e-04 | 105 | 9 | 2 | int:ETV6 | |
| Interaction | CNOT11 interactions | 1.07e-03 | 112 | 9 | 2 | int:CNOT11 | |
| Interaction | C10orf88 interactions | 1.09e-03 | 113 | 9 | 2 | int:C10orf88 | |
| Interaction | C3orf18 interactions | 1.13e-03 | 115 | 9 | 2 | int:C3orf18 | |
| Interaction | AGO4 interactions | 1.19e-03 | 118 | 9 | 2 | int:AGO4 | |
| Interaction | TUT7 interactions | 1.19e-03 | 118 | 9 | 2 | int:TUT7 | |
| Interaction | MARF1 interactions | 1.40e-03 | 128 | 9 | 2 | int:MARF1 | |
| Interaction | R3HDM2 interactions | 1.42e-03 | 129 | 9 | 2 | int:R3HDM2 | |
| Interaction | TCHP interactions | 1.47e-03 | 131 | 9 | 2 | int:TCHP | |
| Interaction | CDCA8 interactions | 1.51e-03 | 133 | 9 | 2 | int:CDCA8 | |
| Interaction | TNRC6C interactions | 1.62e-03 | 138 | 9 | 2 | int:TNRC6C | |
| Interaction | CNOT7 interactions | 1.67e-03 | 140 | 9 | 2 | int:CNOT7 | |
| Interaction | CNOT10 interactions | 1.69e-03 | 141 | 9 | 2 | int:CNOT10 | |
| Interaction | SDC2 interactions | 1.74e-03 | 143 | 9 | 2 | int:SDC2 | |
| Interaction | ANOS1 interactions | 1.74e-03 | 143 | 9 | 2 | int:ANOS1 | |
| Interaction | ZBTB47 interactions | 1.77e-03 | 144 | 9 | 2 | int:ZBTB47 | |
| Interaction | CPEB1 interactions | 1.81e-03 | 146 | 9 | 2 | int:CPEB1 | |
| Interaction | ITSN2 interactions | 1.84e-03 | 147 | 9 | 2 | int:ITSN2 | |
| Interaction | ZNF48 interactions | 1.89e-03 | 149 | 9 | 2 | int:ZNF48 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 3.84e-05 | 25 | 7 | 2 | 775 | |
| Coexpression | GSE13738_RESTING_VS_BYSTANDER_ACTIVATED_CD4_TCELL_UP | 3.25e-05 | 194 | 9 | 3 | M3321 | |
| Coexpression | GSE20727_DNFB_ALLERGEN_VS_ROS_INH_AND_DNFB_ALLERGEN_TREATED_DC_UP | 3.35e-05 | 196 | 9 | 3 | M9241 | |
| Coexpression | GSE12963_ENV_NEF_VS_ENV_NEF_AND_VPR_DEFICIENT_HIV1_INF_CD4_TCELL_DN | 1.16e-03 | 151 | 9 | 2 | M458 | |
| Coexpression | GSE45365_NK_CELL_VS_CD8_TCELL_UP | 1.28e-03 | 159 | 9 | 2 | M10025 | |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_SMALL_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | 1.30e-03 | 680 | 9 | 3 | MM456 | |
| Coexpression | DESCARTES_FETAL_INTESTINE_ENS_NEURONS | 1.31e-03 | 161 | 9 | 2 | M40214 | |
| Coexpression | GSE7348_UNSTIM_VS_TOLERIZED_AND_LPS_STIM_MACROPHAGE_UP | 1.33e-03 | 162 | 9 | 2 | M6847 | |
| Coexpression | FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP | 1.36e-03 | 164 | 9 | 2 | M19957 | |
| Coexpression | DESCARTES_FETAL_PANCREAS_ENS_NEURONS | 1.38e-03 | 165 | 9 | 2 | M40270 | |
| Coexpression | GSE43863_NAIVE_VS_TH1_EFF_CD4_TCELL_D6_LCMV_UP | 1.90e-03 | 194 | 9 | 2 | M9723 | |
| Coexpression | GSE24574_BCL6_LOW_TFH_VS_NAIVE_CD4_TCELL_DN | 1.95e-03 | 197 | 9 | 2 | M8339 | |
| Coexpression | GSE11864_CSF1_VS_CSF1_PAM3CYS_IN_MAC_UP | 1.95e-03 | 197 | 9 | 2 | M3136 | |
| Coexpression | GSE11864_CSF1_VS_CSF1_IFNG_IN_MAC_UP | 1.95e-03 | 197 | 9 | 2 | M3133 | |
| Coexpression | GSE36888_STAT5_AB_KNOCKIN_VS_WT_TCELL_IL2_TREATED_2H_UP | 1.97e-03 | 198 | 9 | 2 | M8730 | |
| Coexpression | GSE22886_DAY0_VS_DAY7_MONOCYTE_IN_CULTURE_UP | 1.99e-03 | 199 | 9 | 2 | M4460 | |
| Coexpression | GSE17721_POLYIC_VS_GARDIQUIMOD_6H_BMDC_DN | 1.99e-03 | 199 | 9 | 2 | M4025 | |
| Coexpression | GSE369_IFNG_KO_VS_WT_LIVER_UP | 1.99e-03 | 199 | 9 | 2 | M5970 | |
| Coexpression | GSE9960_GRAM_NEG_VS_GRAM_NEG_AND_POS_SEPSIS_PBMC_DN | 1.99e-03 | 199 | 9 | 2 | M7131 | |
| Coexpression | GSE36888_UNTREATED_VS_IL2_TREATED_TCELL_17H_UP | 1.99e-03 | 199 | 9 | 2 | M8734 | |
| Coexpression | GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_6H_IFNA_STIM_UP | 1.99e-03 | 199 | 9 | 2 | M7414 | |
| Coexpression | GSE18893_CTRL_VS_TNF_TREATED_TCONV_2H_UP | 2.01e-03 | 200 | 9 | 2 | M7295 | |
| Coexpression | GSE41867_NAIVE_VS_DAY15_LCMV_EFFECTOR_CD8_TCELL_DN | 2.01e-03 | 200 | 9 | 2 | M9472 | |
| Coexpression | GSE17721_POLYIC_VS_CPG_0.5H_BMDC_DN | 2.01e-03 | 200 | 9 | 2 | M3933 | |
| Coexpression | GSE17721_PAM3CSK4_VS_GADIQUIMOD_2H_BMDC_DN | 2.01e-03 | 200 | 9 | 2 | M3965 | |
| Coexpression | GSE17721_PAM3CSK4_VS_GADIQUIMOD_16H_BMDC_DN | 2.01e-03 | 200 | 9 | 2 | M3978 | |
| Coexpression | GSE36392_EOSINOPHIL_VS_NEUTROPHIL_IL25_TREATED_LUNG_UP | 2.01e-03 | 200 | 9 | 2 | M5282 | |
| Coexpression | GSE36392_TYPE_2_MYELOID_VS_EOSINOPHIL_IL25_TREATED_LUNG_DN | 2.01e-03 | 200 | 9 | 2 | M5271 | |
| Coexpression | GSE31082_DN_VS_DP_THYMOCYTE_DN | 2.01e-03 | 200 | 9 | 2 | M5055 | |
| Coexpression | GSE14308_TH1_VS_INDUCED_TREG_UP | 2.01e-03 | 200 | 9 | 2 | M3378 | |
| Coexpression | GSE23695_CD57_POS_VS_NEG_NK_CELL_DN | 2.01e-03 | 200 | 9 | 2 | M7786 | |
| Coexpression | GSE3039_ALPHABETA_CD8_TCELL_VS_B1_BCELL_UP | 2.01e-03 | 200 | 9 | 2 | M6447 | |
| Coexpression | GSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA5_STIM_CD8_TCELL_UP | 2.01e-03 | 200 | 9 | 2 | M8050 | |
| Coexpression | GSE20198_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_DN | 2.01e-03 | 200 | 9 | 2 | M7361 | |
| Coexpression | GSE360_DC_VS_MAC_UP | 2.01e-03 | 200 | 9 | 2 | M5172 | |
| Coexpression | GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_48H_UP | 2.01e-03 | 200 | 9 | 2 | M6044 | |
| Coexpression | GSE360_L_DONOVANI_VS_L_MAJOR_DC_UP | 2.01e-03 | 200 | 9 | 2 | M5192 | |
| Coexpression | GSE37532_WT_VS_PPARG_KO_LN_TCONV_UP | 2.01e-03 | 200 | 9 | 2 | M8954 | |
| Coexpression | GSE6681_DELETED_FOXP3_VS_WT_TREG_DN | 2.01e-03 | 200 | 9 | 2 | M6779 | |
| Coexpression | GSE5679_CTRL_VS_RARA_AGONIST_AM580_TREATED_DC_UP | 2.01e-03 | 200 | 9 | 2 | M6555 | |
| Coexpression | GSE3203_HEALTHY_VS_INFLUENZA_INFECTED_LN_BCELL_UP | 2.01e-03 | 200 | 9 | 2 | M6785 | |
| Coexpression | GSE21670_UNTREATED_VS_IL6_TREATED_CD4_TCELL_DN | 2.01e-03 | 200 | 9 | 2 | M7441 | |
| Coexpression | PROVENZANI_METASTASIS_UP | 2.09e-03 | 204 | 9 | 2 | M4100 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_26.46.91|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.90e-04 | 129 | 9 | 2 | 6abdba987c8528f7cb90b32dc01796e02c7352c9 | |
| ToppCell | Control-Neu_1|World / 5 Neutrophil clusters in COVID-19 patients | 3.32e-04 | 138 | 9 | 2 | b7920c9a28d28220e7e4b30cd91ba13d0548eb76 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-Neutrophil-Neu_1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.51e-04 | 142 | 9 | 2 | 191a13bba143ecdfc2bfd797c3ac191481388298 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-Neutrophil-Neu_1|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.56e-04 | 143 | 9 | 2 | b405dba9a83a99cc7b53ce71772bc52a0bbb0d4e | |
| ToppCell | TCGA-Peripheral_Nervous_System|World / Sample_Type by Project: Shred V9 | 3.61e-04 | 144 | 9 | 2 | 3bbadb4b07ffb461d5400a5d69ad3b259f74041e | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid-myeloid_leukocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.34e-04 | 158 | 9 | 2 | 91d265e95156f16459924d3e4dd11c180e164eee | |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-7|TCGA-Liver / Sample_Type by Project: Shred V9 | 4.40e-04 | 159 | 9 | 2 | 70288df54adab167c0f50675128619299077db11 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Myeloid-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.56e-04 | 162 | 9 | 2 | b502d6af6868425b5c919740e011330c0d3cf3b8 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.56e-04 | 162 | 9 | 2 | 93bd29c52846c3156b8b0d2e39c552373efdfe93 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.85e-04 | 167 | 9 | 2 | 3dfec2fcc36caa6e394efae5e540a6fa28759977 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.85e-04 | 167 | 9 | 2 | 9480739587d51e67a281778b9bddd7b5ffc3ad92 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.85e-04 | 167 | 9 | 2 | 95b3b5ba3414729f0460a26a0deca48de0cbe33e | |
| ToppCell | 3'_v3-lymph-node_spleen|World / Manually curated celltypes from each tissue | 5.08e-04 | 171 | 9 | 2 | 7aae88da5b37c20f10118325a048f08906be994c | |
| ToppCell | droplet-Lung-nan-18m-Lymphocytic-Proliferating_NK|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.14e-04 | 172 | 9 | 2 | e495efd25aec60b97ac2b5aa861651bd73174a17 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.26e-04 | 174 | 9 | 2 | c2f8c59fca5f1ff6ffa6dc8cfce62da4b19fe9b3 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal-Deuterosomal_L.0.3.4.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.26e-04 | 174 | 9 | 2 | 0227fea1678baa9168bd47c3b4aacb2592bb5867 | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.26e-04 | 174 | 9 | 2 | 84024c04b0ce9f7068677d2d99ede56882b7dbd2 | |
| ToppCell | 3'-Adult-Appendix-Epithelial-mature_enterocytic-Colonocyte|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.38e-04 | 176 | 9 | 2 | 23fa02d4c39e0b8faa1658116d50b6233a952ccc | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-neurons_B-Branch_B3_(IPAN)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.38e-04 | 176 | 9 | 2 | 04dad262929581872e5bbc66cd8182c963e7e52f | |
| ToppCell | 356C-Myeloid-Dendritic-cDC_proliferating_2|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.38e-04 | 176 | 9 | 2 | 4bba41ebf9dd187c8705a6997ed039878de62b4e | |
| ToppCell | droplet-Lung-18m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell-proliferating_NK|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.38e-04 | 176 | 9 | 2 | b17317ac41d3215db55a38cbd3366c0947f7a2a3 | |
| ToppCell | 3'-Adult-Appendix-Epithelial-mature_enterocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.38e-04 | 176 | 9 | 2 | 30adf8f1638c6244586f8101c2590bb964dfae00 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 5.44e-04 | 177 | 9 | 2 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.50e-04 | 178 | 9 | 2 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.50e-04 | 178 | 9 | 2 | 1bddbc083c36657bd6910f7466126ab325e88176 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.50e-04 | 178 | 9 | 2 | a74e5a390cbeaca9de1fdb7b2a0e50783bd202dd | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.56e-04 | 179 | 9 | 2 | a3922476f33d2e4137a12dbda21a1703dff79684 | |
| ToppCell | wk_15-18-Epithelial-PNS-KCNIP4+_neuron|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 5.56e-04 | 179 | 9 | 2 | e20bfdfb6d5af8556eb66b81a19fbe4e3e28334a | |
| ToppCell | 368C-Lymphocytic-ILC-ILC-2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 5.63e-04 | 180 | 9 | 2 | eb5a57604c7f2ad256c300085dbf5069d0ae1ad0 | |
| ToppCell | 368C-Lymphocytic-ILC|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 5.63e-04 | 180 | 9 | 2 | ddba4dc3bbcfe4e4a22400be73bbc62d3ff27d3c | |
| ToppCell | cellseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Deuterosomal|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.75e-04 | 182 | 9 | 2 | deb53a4f84e4cd5c3b4180a4ac43249da9d738f7 | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Neurosecretory-PNEC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.75e-04 | 182 | 9 | 2 | 1923932a9c60e9ec33db69ded441210d1fb07bec | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Neurosecretory-PNEC-PNEC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.75e-04 | 182 | 9 | 2 | 69ff652f74cc47fbe0bd665ab17c445c5b959dad | |
| ToppCell | normal-na-Lymphocytic_T-T8_naive-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 5.88e-04 | 184 | 9 | 2 | 4a81190b36d197736663e6177d3b76c1cb6282d6 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.88e-04 | 184 | 9 | 2 | 7d9bcdaff8cbea4c50ab7db0f8e01f6bbd0ef593 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-neurons_B-Branch_B2_(eMN)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.00e-04 | 186 | 9 | 2 | 24b23880d4ff8fb4a23e2012d5890b9e2fcf7283 | |
| ToppCell | Substantia_nigra-Neuronal|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 6.00e-04 | 186 | 9 | 2 | 3f889083fcffe516388e9b03a5e23af2010ced33 | |
| ToppCell | Control-Lymphoid-ILC_A|World / Disease state, Lineage and Cell class | 6.00e-04 | 186 | 9 | 2 | 7bc939bf4e71bb4c6409b862c1f6c547d775e089 | |
| ToppCell | wk_15-18-Epithelial-PNS-MFNG+_DBH+_neuron|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 6.00e-04 | 186 | 9 | 2 | 72f7427d62d65e37bb0bf99229a1b75df081a128 | |
| ToppCell | droplet-Heart-HEART-1m-Neuronal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.00e-04 | 186 | 9 | 2 | fddc6b93f98b10aaf8d4ebc142b46d8213f3129d | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 6.00e-04 | 186 | 9 | 2 | 9d3efe2a4feea2bc205a7e45b9b9f9ed9b3609ce | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.07e-04 | 187 | 9 | 2 | 629b3e05840eb10e598b8dfaabd92ebe02f9995a | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.07e-04 | 187 | 9 | 2 | 2f153b203fe79f206319603cf94d3a03ab49a05d | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-neurons_A-Branch_A1_(iMN)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.07e-04 | 187 | 9 | 2 | a748b3a59e398e0da019db3f16d38adb1960c29f | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.07e-04 | 187 | 9 | 2 | 1b2fdbfb1ce3f19795dfc4b1da5a94f4b057ec41 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal-Deuterosomal_L.0.3.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.07e-04 | 187 | 9 | 2 | 269145d71576cbe8fa217090c8aac82d915dbc04 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.07e-04 | 187 | 9 | 2 | 7a50aded3243bef2075fb3ec550939ce0694919a | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.07e-04 | 187 | 9 | 2 | e04a84989d624378141042768383b9c846901f2d | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.07e-04 | 187 | 9 | 2 | 24cc03c748e15f7ef0e6509ca5a6ca583fb9c573 | |
| ToppCell | wk_08-11-Epithelial-PNS-MFNG+_DBH+_neuron|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 6.13e-04 | 188 | 9 | 2 | d3d7d21d4fa39ac4106a164652673de1bef8662d | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neuron_precursor-cycling_neuroblast|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.20e-04 | 189 | 9 | 2 | 815afad947ed77a8b03724bf78014799fed34f54 | |
| ToppCell | ILEUM-inflamed-(5)_Plasma-(5)_IgA_plasma_cells|(5)_Plasma / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 6.20e-04 | 189 | 9 | 2 | a0634d72bfdd5f93877724ed6480b50a3a046f71 | |
| ToppCell | Globus_pallidus-Neuronal|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 6.26e-04 | 190 | 9 | 2 | 416de85d8841dac883faa6f5339b2fb461a09e82 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_Prolif-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.39e-04 | 192 | 9 | 2 | f518839ecd9377537a414e8798766f7d91eafeac | |
| ToppCell | Entopeduncular-Neuronal|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 6.39e-04 | 192 | 9 | 2 | 4c35e5c28a40b439044797ba1f06cb7c36b2a8de | |
| ToppCell | Posterior_cortex-Neuronal|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 6.46e-04 | 193 | 9 | 2 | b4989e3436e84dbec3789b46057e0f7a0ebf09d4 | |
| ToppCell | Thalamus-Neuronal|Thalamus / BrainAtlas - Mouse McCarroll V32 | 6.46e-04 | 193 | 9 | 2 | 712a4acd1167e43543950bc819ff11984e6f718d | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD8-Tnaive/CM_CD8|blood / Manually curated celltypes from each tissue | 6.53e-04 | 194 | 9 | 2 | 390bf41cccfd586725a2fe653a299a78e261ec9b | |
| ToppCell | nucseq-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.59e-04 | 195 | 9 | 2 | ffb40486f8097b2c08e8f3b3685d0b8cb8d1bc66 | |
| ToppCell | nucseq-Immune-Lymphocytic_T/NK|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.59e-04 | 195 | 9 | 2 | b8124e8a23e6d37b40023608674e67285c6ffe84 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 6.59e-04 | 195 | 9 | 2 | 4bdedd924564a260841a9153604026b57487c83d | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-neurons_B|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.73e-04 | 197 | 9 | 2 | a1ae1aa797762a3768e14434c7e5cd19c595ecb3 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_A-Branch_A1_(iMN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.73e-04 | 197 | 9 | 2 | fd43fc1cbf0c17b370397d73dddc572565a759c7 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-neurons_A|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.80e-04 | 198 | 9 | 2 | 50504a3871f76d6a5b439a56450d7770f4501eb0 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal-neurons_A-Branch_A1_(iMN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.80e-04 | 198 | 9 | 2 | dac7b68bb8f1c4d8aa7fdfada61f79956866e874 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal-neuron_precursor-cycling_neuroblast|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.80e-04 | 198 | 9 | 2 | 2ee8ac82ef1b8ebabc8dd824211bbb471f2af8ac | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.80e-04 | 198 | 9 | 2 | a3bd099ef0e606c2da690a6fcf6f79e9360c9c9f | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 6.87e-04 | 199 | 9 | 2 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW13-Stem_cells-Stem_cells|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 6.87e-04 | 199 | 9 | 2 | 91882af9dc7265c9b419f4415cbcf656087a2ab3 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW13-Stem_cells|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 6.87e-04 | 199 | 9 | 2 | fd1d1b95e01719e3d0a17d9d1f29717a47209d32 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 6.87e-04 | 199 | 9 | 2 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 6.93e-04 | 200 | 9 | 2 | ac0e023dbb383bbc46c5cc525431778be8f7ef46 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Intermediate|5w / Sample Type, Dataset, Time_group, and Cell type. | 6.93e-04 | 200 | 9 | 2 | c92e4fc0442404481fcac623d691dae6215b852d | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW13-Stem_cells|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 6.93e-04 | 200 | 9 | 2 | d933978b55fefe52cad599b36f6b47a0c7f71f96 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW13-Stem_cells-Neuroepithelial_cell|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 6.93e-04 | 200 | 9 | 2 | 3d932765c31aef1f80a118d51e8e66c50a758dbb | |
| Drug | Cyproterone acetate [427-51-0]; Down 200; 9.6uM; PC3; HT_HG-U133A | 4.93e-05 | 194 | 9 | 3 | 4470_DN | |
| Drug | Flunarizine dihydrochloride [30484-77-6]; Up 200; 8.4uM; PC3; HT_HG-U133A | 5.08e-05 | 196 | 9 | 3 | 7252_UP | |
| Drug | Saquinavir mesylate [149845-06-7]; Down 200; 5.2uM; PC3; HT_HG-U133A | 5.16e-05 | 197 | 9 | 3 | 5770_DN | |
| Drug | Scopolamine hydrochloride [55-16-3]; Up 200; 11.8uM; HL60; HT_HG-U133A | 5.24e-05 | 198 | 9 | 3 | 3018_UP | |
| Drug | Reserpine [50-55-5]; Up 200; 6.6uM; HL60; HT_HG-U133A | 5.31e-05 | 199 | 9 | 3 | 3003_UP | |
| Drug | AC1MMLID | 5.71e-04 | 92 | 9 | 2 | CID000013245 | |
| Drug | Asp-pro | 7.29e-04 | 104 | 9 | 2 | CID000170612 | |
| Drug | carbonyl cyanide m-chlorophenylhydrazone | 1.05e-03 | 125 | 9 | 2 | CID000002603 | |
| Drug | ellagic acid | 1.65e-03 | 157 | 9 | 2 | CID005281855 | |
| Drug | bromfenacoum | 1.67e-03 | 644 | 9 | 3 | ctd:C013418 | |
| Drug | Coal Ash | 1.69e-03 | 159 | 9 | 2 | ctd:D060729 | |
| Drug | Clorgyline | 1.88e-03 | 168 | 9 | 2 | ctd:D003010 | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; PC3; HT_HG-U133A | 1.93e-03 | 170 | 9 | 2 | 6736_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; PC3; HT_HG-U133A | 2.00e-03 | 173 | 9 | 2 | 2105_UP | |
| Drug | trichostatin A, Streptomyces sp.; Up 200; 1uM; PC3; HT_HG-U133A | 2.00e-03 | 173 | 9 | 2 | 7105_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; PC3; HT_HG-U133A | 2.00e-03 | 173 | 9 | 2 | 7285_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; PC3; HT_HG-U133A | 2.02e-03 | 174 | 9 | 2 | 6609_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; PC3; HT_HG-U133A | 2.02e-03 | 174 | 9 | 2 | 2084_UP | |
| Drug | radicicol, diheterospora chlamydosporia; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA | 2.04e-03 | 175 | 9 | 2 | 1057_UP | |
| Drug | TMB-8 | 2.06e-03 | 176 | 9 | 2 | CID000005494 | |
| Drug | trichostatin A, Streptomyces sp.; Up 200; 1uM; PC3; HT_HG-U133A | 2.06e-03 | 176 | 9 | 2 | 6546_UP | |
| Drug | trichostatin A, Streptomyces sp.; Up 200; 1uM; PC3; HT_HG-U133A | 2.06e-03 | 176 | 9 | 2 | 7047_UP | |
| Drug | Phenoxybenzamine hydrochloride [63-92-3]; Down 200; 11.8uM; PC3; HT_HG-U133A | 2.09e-03 | 177 | 9 | 2 | 4652_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; PC3; HT_HG-U133A | 2.09e-03 | 177 | 9 | 2 | 7387_UP | |
| Drug | trichostatin A, Streptomyces sp.; Up 200; 1uM; PC3; HT_HG-U133A | 2.11e-03 | 178 | 9 | 2 | 5940_UP | |
| Drug | valinomycin; Up 200; 0.1uM; PC3; HT_HG-U133A | 2.13e-03 | 179 | 9 | 2 | 5962_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; PC3; HT_HG-U133A | 2.13e-03 | 179 | 9 | 2 | 5086_UP | |
| Drug | trichostatin A, Streptomyces sp.; Up 200; 1uM; PC3; HT_HG-U133A | 2.16e-03 | 180 | 9 | 2 | 5950_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; PC3; HT_HG-U133A | 2.18e-03 | 181 | 9 | 2 | 5822_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; PC3; HT_HG-U133A | 2.18e-03 | 181 | 9 | 2 | 3688_UP | |
| Drug | trichostatin A, Streptomyces sp.; Up 200; 1uM; PC3; HT_HG-U133A | 2.20e-03 | 182 | 9 | 2 | 7503_UP | |
| Drug | Forskolin, from Coleus forskohlii; Up 200; 0.5uM; PC3; HT_HG-U133A | 2.23e-03 | 183 | 9 | 2 | 7059_UP | |
| Drug | trichostatin A, Streptomyces sp.; Up 200; 1uM; PC3; HT_HG-U133A | 2.23e-03 | 183 | 9 | 2 | 6874_UP | |
| Drug | GW8510; Up 200; 10uM; PC3; HT_HG-U133A | 2.30e-03 | 186 | 9 | 2 | 7067_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; PC3; HT_HG-U133A | 2.35e-03 | 188 | 9 | 2 | 5882_UP | |
| Drug | Tolazoline hydrochloride [59-97-2]; Up 200; 20.4uM; HL60; HG-U133A | 2.35e-03 | 188 | 9 | 2 | 2000_UP | |
| Drug | Trifluoperazine dihydrochloride [440-17-5]; Up 200; 8.4uM; MCF7; HT_HG-U133A | 2.35e-03 | 188 | 9 | 2 | 5442_UP | |
| Drug | CP-319743 [172078-87-4]; Up 200; 10uM; PC3; HT_HG-U133A | 2.37e-03 | 189 | 9 | 2 | 7537_UP | |
| Drug | Butamben [94-25-7]; Down 200; 20.6uM; PC3; HT_HG-U133A | 2.42e-03 | 191 | 9 | 2 | 5792_DN | |
| Drug | 0393-0188; Up 200; 10uM; PC3; HT_HG-U133A | 2.45e-03 | 192 | 9 | 2 | 7536_UP | |
| Drug | Azacyclonol [115-46-8]; Down 200; 15uM; PC3; HG-U133A | 2.45e-03 | 192 | 9 | 2 | 1937_DN | |
| Drug | Tranylcypromine hydrochloride [1986-47-6]; Down 200; 23.6uM; PC3; HT_HG-U133A | 2.45e-03 | 192 | 9 | 2 | 2101_DN | |
| Drug | Fenoterol hydrobromide [1944-12-3]; Down 200; 10.4uM; HL60; HT_HG-U133A | 2.45e-03 | 192 | 9 | 2 | 2378_DN | |
| Drug | 2-propylpentanoic acid; Up 200; 50uM; HL60; HT_HG-U133A | 2.47e-03 | 193 | 9 | 2 | 2682_UP | |
| Drug | 0316684-0000 [391209-55-5]; Up 200; 10uM; PC3; HT_HG-U133A | 2.47e-03 | 193 | 9 | 2 | 7057_UP | |
| Drug | Chlorprothixene hydrochloride [6469-93-8]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 2.47e-03 | 193 | 9 | 2 | 5291_DN | |
| Drug | Rapamycin; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.47e-03 | 193 | 9 | 2 | 4431_DN | |
| Drug | geldanamycin; Down 200; 1uM; PC3; HT_HG-U133A | 2.47e-03 | 193 | 9 | 2 | 1228_DN | |
| Drug | Chlortetracycline hydrochloride [64-72-2]; Down 200; 7.8uM; PC3; HG-U133A | 2.47e-03 | 193 | 9 | 2 | 1958_DN | |
| Drug | carmustine; Down 200; 100uM; PC3; HT_HG-U133A | 2.50e-03 | 194 | 9 | 2 | 6883_DN | |
| Drug | Decamethonium bromide [541-22-0]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 2.50e-03 | 194 | 9 | 2 | 4174_DN | |
| Drug | Meropenem [96036-03-2]; Up 200; 10.4uM; PC3; HT_HG-U133A | 2.50e-03 | 194 | 9 | 2 | 5824_UP | |
| Drug | Cyanocobalamin [68-19-9]; Down 200; 3uM; PC3; HT_HG-U133A | 2.50e-03 | 194 | 9 | 2 | 4572_DN | |
| Drug | Fusaric acid [536-69-6]; Up 200; 22.4uM; HL60; HT_HG-U133A | 2.50e-03 | 194 | 9 | 2 | 1308_UP | |
| Drug | (S)-(-)-Cycloserine [339-72-0]; Down 200; 39.2uM; PC3; HT_HG-U133A | 2.50e-03 | 194 | 9 | 2 | 4524_DN | |
| Drug | Tiapride hydrochloride [51012-33-0]; Down 200; 11uM; PC3; HT_HG-U133A | 2.53e-03 | 195 | 9 | 2 | 7362_DN | |
| Drug | Canrenoic acid potassium salt [2181-04-6]; Up 200; 10uM; PC3; HT_HG-U133A | 2.53e-03 | 195 | 9 | 2 | 7135_UP | |
| Drug | Clomiphene citrate (Z,E) [50-41-9]; Down 200; 6.6uM; PC3; HT_HG-U133A | 2.53e-03 | 195 | 9 | 2 | 6648_DN | |
| Drug | Talampicillin hydrochloride [39878-70-1]; Up 200; 7.8uM; PC3; HT_HG-U133A | 2.53e-03 | 195 | 9 | 2 | 7254_UP | |
| Drug | Homosalate [118-56-9]; Down 200; 15.2uM; PC3; HT_HG-U133A | 2.53e-03 | 195 | 9 | 2 | 4533_DN | |
| Drug | Methazolamide [554-57-4]; Up 200; 17uM; HL60; HT_HG-U133A | 2.53e-03 | 195 | 9 | 2 | 2733_UP | |
| Drug | Kaempferol [520-18-3]; Up 200; 14uM; HL60; HT_HG-U133A | 2.53e-03 | 195 | 9 | 2 | 6157_UP | |
| Drug | Moxisylyte hydrochoride [964-52-3]; Up 200; 12.6uM; PC3; HT_HG-U133A | 2.53e-03 | 195 | 9 | 2 | 7255_UP | |
| Drug | Trimethoprim [738-70-5]; Up 200; 13.8uM; PC3; HT_HG-U133A | 2.53e-03 | 195 | 9 | 2 | 7377_UP | |
| Drug | Prazosin hydrochloride [19237-84-4]; Down 200; 9.6uM; PC3; HT_HG-U133A | 2.55e-03 | 196 | 9 | 2 | 6315_DN | |
| Drug | Nisoxetine hydrochloride [57754-86-6]; Down 200; 13uM; PC3; HT_HG-U133A | 2.55e-03 | 196 | 9 | 2 | 5091_DN | |
| Drug | Retrorsine [480-54-6]; Down 200; 11.4uM; PC3; HT_HG-U133A | 2.55e-03 | 196 | 9 | 2 | 6601_DN | |
| Drug | estradiol, USP; Down 200; 0.01uM; MCF7; HT_HG-U133A_EA | 2.55e-03 | 196 | 9 | 2 | 1021_DN | |
| Drug | Gossypol [303-45-7]; Down 200; 7.8uM; PC3; HT_HG-U133A | 2.55e-03 | 196 | 9 | 2 | 4296_DN | |
| Drug | Nifenazone [2139-47-1]; Up 200; 13uM; PC3; HT_HG-U133A | 2.55e-03 | 196 | 9 | 2 | 7314_UP | |
| Drug | Betazole hydrochloride; Down 200; 27uM; PC3; HT_HG-U133A | 2.55e-03 | 196 | 9 | 2 | 6344_DN | |
| Drug | Bezafibrate [41859-67-0]; Down 200; 11uM; PC3; HT_HG-U133A | 2.55e-03 | 196 | 9 | 2 | 6653_DN | |
| Drug | Dicumarol [66-76-2]; Down 200; 11.8uM; PC3; HT_HG-U133A | 2.55e-03 | 196 | 9 | 2 | 3766_DN | |
| Drug | Pancuronium bromide [15500-66-0]; Down 200; 5.4uM; PC3; HT_HG-U133A | 2.55e-03 | 196 | 9 | 2 | 4570_DN | |
| Drug | Metanephrine hydrochloride DL [881-95-8]; Up 200; 17.2uM; HL60; HG-U133A | 2.55e-03 | 196 | 9 | 2 | 2015_UP | |
| Drug | Thioperamide maleate [106243-16-7]; Up 200; 9.8uM; HL60; HT_HG-U133A | 2.55e-03 | 196 | 9 | 2 | 3055_UP | |
| Drug | Guaifenesin [93-14-1]; Down 200; 20.2uM; PC3; HT_HG-U133A | 2.55e-03 | 196 | 9 | 2 | 4549_DN | |
| Drug | Proadifen hydrochloride [62-68-0]; Up 200; 10.2uM; PC3; HT_HG-U133A | 2.55e-03 | 196 | 9 | 2 | 5807_UP | |
| Drug | Y-27632; Up 200; 3uM; MCF7; HT_HG-U133A_EA | 2.55e-03 | 196 | 9 | 2 | 832_UP | |
| Drug | GSK-3 Inhibitor IX; Down 200; 0.5uM; PC3; HT_HG-U133A | 2.55e-03 | 196 | 9 | 2 | 6585_DN | |
| Drug | Trimethoprim [738-70-5]; Up 200; 13.8uM; PC3; HT_HG-U133A | 2.55e-03 | 196 | 9 | 2 | 3678_UP | |
| Drug | Clemizole hydrochloride [1163-36-6]; Up 200; 11uM; MCF7; HT_HG-U133A | 2.55e-03 | 196 | 9 | 2 | 2301_UP | |
| Drug | Liothyronine [6893-02-3]; Down 200; 6.2uM; PC3; HT_HG-U133A | 2.55e-03 | 196 | 9 | 2 | 6602_DN | |
| Drug | Alfuzosin hydrochloride [81403-68-1]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 2.58e-03 | 197 | 9 | 2 | 5605_UP | |
| Drug | Clorsulon [60200-06-8]; Up 200; 10.6uM; PC3; HT_HG-U133A | 2.58e-03 | 197 | 9 | 2 | 7264_UP | |
| Drug | 17-DMAG; Down 200; 0.1uM; HL60; HT_HG-U133A | 2.58e-03 | 197 | 9 | 2 | 1154_DN | |
| Drug | U0125; Down 200; 1uM; PC3; HG-U133A | 2.58e-03 | 197 | 9 | 2 | 663_DN | |
| Drug | Succinylsulfathiazole [116-43-8]; Up 200; 11.2uM; HL60; HT_HG-U133A | 2.58e-03 | 197 | 9 | 2 | 2166_UP | |
| Drug | Sulfanilamide [63-74-1]; Down 200; 23.2uM; PC3; HT_HG-U133A | 2.58e-03 | 197 | 9 | 2 | 4474_DN | |
| Drug | 2-Aminobenzenesulfonamide [3306-62-5]; Up 200; 23.2uM; HL60; HT_HG-U133A | 2.58e-03 | 197 | 9 | 2 | 3063_UP | |
| Drug | Ethaverine hydrochloride [985-13-7]; Down 200; 9.2uM; PC3; HT_HG-U133A | 2.58e-03 | 197 | 9 | 2 | 6737_DN | |
| Disease | grip strength measurement | 3.75e-03 | 350 | 8 | 2 | EFO_0006941 | |
| Disease | cortical surface area measurement | 4.45e-03 | 1345 | 8 | 3 | EFO_0010736 | |
| Disease | Intellectual Disability | 6.04e-03 | 447 | 8 | 2 | C3714756 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KKDKKGKQQDGAMES | 301 | Q16720 | |
| TCNSNDGKKKGMGKK | 1011 | P29323 | |
| KKGKEKGGKNAINMK | 91 | P21579 | |
| KKGLQKGMKTSGKQD | 921 | Q9HCJ0 | |
| GIKKKSNKKTNEHGM | 381 | Q562F6 | |
| EGKNQKQGKGKTCKK | 31 | Q8N3U4 | |
| AEVGKKGKKKCQKQG | 86 | O43159 | |
| KGHGSKMEKGLQKKK | 41 | Q5VYS8 | |
| GGKKQMKCSLKGGNN | 1041 | Q9UPQ9 |